Melasma and Lasers: What Actually Helps, What Backfires, and Why

Walk into almost any laser practice on the Westside and you will hear the same question: can a laser erase my melasma? The honest answer, supported by the dermatology literature, is more complicated than most marketing suggests. Lasers can play a role in melasma management, but they are an adjunct, not a cure, and several popular devices can make the condition visibly worse within weeks. This piece breaks down the mechanisms so you can evaluate what you are being offered.

First, what melasma actually is. Melasma is not simply extra pigment sitting in the skin waiting to be blasted out. It is a chronic, relapsing disorder driven by overactive melanocytes, the pigment-producing cells, which are stimulated by ultraviolet light, visible light, heat, and hormones. Research over the past decade has also implicated increased blood vessel density in melasma patches and signaling between vessels, fibroblasts, and melanocytes. In other words, the pigment you see is the output of a system that is switched on, and removing pigment without addressing the switch invites recurrence. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

Why heat is the enemy. Most lasers work through photothermal effects, meaning they convert light into heat inside a target. In melasma, heat itself is a trigger. Melanocytes in melasma-prone skin respond to thermal stress by producing more pigment, a phenomenon closely related to post-inflammatory hyperpigmentation. This is why aggressive settings on intense pulsed light, long-pulsed devices, or high-density fractional lasers frequently produce a short honeymoon of lighter skin followed by rebound darkening one to three months later. Patients often interpret the rebound as new melasma. It is usually the treatment.

The myth: one series of laser sessions clears melasma permanently. No device has demonstrated durable, monotherapy clearance of melasma in controlled studies. Recurrence rates after laser treatment alone are high, particularly in patients with Fitzpatrick skin types III to V, which describes a large share of the Los Angeles population. Any consultation that promises permanent clearance from lasers alone deserves skepticism.

Where lasers genuinely help. The device category with the strongest evidence is the low-fluence Q-switched or picosecond 1064 nm Nd:YAG, often marketed as laser toning. At low energy, these ultrashort pulses fracture melanosomes, the pigment packets inside cells, through a photoacoustic effect rather than bulk heating. Because the pulse is measured in nanoseconds or picoseconds, energy is delivered faster than heat can spread to surrounding tissue, which limits the thermal trigger described above. Studies show meaningful lightening over a series of weekly or biweekly sessions. The tradeoffs are real: results are gradual, maintenance is usually required, and overtreatment with too many low-fluence sessions has been linked to punctate hypopigmentation, small white spots that can be permanent. Conservative session counts and spacing matter.

Picosecond lasers with fractionated handpieces, and low-density non-ablative fractional lasers at 1550 nm or 1927 nm, also have supportive data when used gently. The 1927 nm thulium wavelength targets water in the superficial epidermis, where much melasma pigment sits, and can improve penetration of topical lightening agents applied afterward. Again, the operative word is gentle. Density and energy settings appropriate for photoaging are often too aggressive for melasma.

What tends to backfire. Intense pulsed light contains wavelengths absorbed by both melanin and hemoglobin and delivers relatively long pulses, which means significant heat. Some patients with mixed sun damage and melasma see initial improvement, but rebound is common. Ablative resurfacing, including fully ablative CO2, has a poor track record for melasma and a substantial risk of post-inflammatory hyperpigmentation in medium and darker skin tones. High-fluence Q-switched treatments intended for tattoos or discrete sun spots are similarly risky on melasma patches.

The part no laser can replace. Every credible melasma protocol is built on strict photoprotection, including protection against visible light, which standard chemical sunscreens do not block. Tinted mineral sunscreens containing iron oxides address the visible light component. Topical therapy, typically hydroquinone-based combinations or alternatives such as azelaic acid and cysteamine, remains first line. Oral tranexamic acid, prescribed and monitored by a physician for appropriate candidates, has become a common addition because it appears to interrupt the vascular and inflammatory signaling that feeds melanocyte activity. Lasers, when used, sit on top of this foundation, usually to accelerate improvement in stubborn areas.

Questions worth asking at a Beverly Hills consultation. Ask which wavelength and pulse duration will be used and why it suits melasma specifically. Ask what the plan is if rebound pigmentation appears. Ask whether topical therapy and photoprotection are part of the protocol, because if the answer is that the laser alone will handle it, the science says otherwise. Melasma rewards patience and layered treatment. It punishes heat, haste, and promises of permanence.